{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:22:42Z","timestamp":1789233762058,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabres.2025.112913","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:13:03Z","timestamp":1758575583000},"page":"112913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3239-1825","authenticated-orcid":false,"given":"Shunsuke","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7897-3688","authenticated-orcid":false,"given":"Ayaka","family":"Kokita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Akanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5711-6456","authenticated-orcid":false,"given":"Shogo","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-540X","authenticated-orcid":false,"given":"Yuya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kusumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7508-8528","authenticated-orcid":false,"given":"Kana","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-8564","authenticated-orcid":false,"given":"Mitsuhiko","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4587-6281","authenticated-orcid":false,"given":"Aiko","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenobu","family":"Tadika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-849X","authenticated-orcid":false,"given":"Takehiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-9793","authenticated-orcid":false,"given":"Hironori","family":"Waki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112913_b0005","unstructured":"Ministry of Health, Labour and Welfare. The National Health and Nutrition Survey in Japan, 2023. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/eiyou\/r5-houkoku_00001.html (accessed September 5, 2025)."},{"key":"10.1016\/j.diabres.2025.112913_b0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1248\/bpb.b22-00710","article-title":"Prescription trends for the antidiabetic agents used to treat type 2 diabetes mellitus in Japan from 2012\u20132020: a time-series analysis","volume":"46","author":"Iketani","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.diabres.2025.112913_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110841","article-title":"Real-world use of glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes: a retrospective database study (DEFINE-G)","volume":"203","author":"Ohsugi","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112913_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112913_b0025","article-title":"Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: results from the SURMOUNT-1 study","author":"Gudzune","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112913_b0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial","volume":"398","author":"Ludvik","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112913_b0035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/clinem\/dgae038","article-title":"Tirzepatide improved markers of islet cell function and insulin sensitivity in people with T2D (SURPASS-2)","volume":"109","author":"Frias","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112913_b0040","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s13300-023-01485-3","article-title":"Treatment satisfaction and quality of life with tirzepatide versus dulaglutide among japanese patients with type 2 diabetes: exploratory evaluation of the SURPASS J-mono trial","volume":"14","author":"Ishii","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2025.112913_b0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S2213-8587(22)00188-7","article-title":"Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial","volume":"10","author":"Inagaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2025.112913_b0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s13300-025-01723-w","article-title":"Tirzepatide was associated with improved health-related quality of life in adults with obesity or overweight and type 2 diabetes: results from the phase 3 SURMOUNT-2 trial","volume":"16","author":"Hunter Gibble","year":"2025","journal-title":"Diab Ther"},{"key":"10.1016\/j.diabres.2025.112913_b0055","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/dom.15493","article-title":"Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: a multicentre, prospective real-world study (PIONEER REAL Canada)","volume":"26","author":"Jain","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112913_b0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/dom.14998","volume":"25","author":"Takahashi","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112913_b0065","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s13300-023-01451-z","article-title":"Patient-reported outcomes in people with type 2 diabetes receiving tirzepatide in the SURPASS clinical trial programme","volume":"14","author":"Boye","year":"2023","journal-title":"Diab Ther"},{"issue":"Suppl 3","key":"10.1016\/j.diabres.2025.112913_b0070","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/dmrr.279","article-title":"Patient perceptions of diabetes and diabetes therapy: assessing quality of life","volume":"18","author":"Bradley","year":"2002","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.diabres.2025.112913_b0075","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2025.112913_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108779","article-title":"Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus","volume":"38","author":"Suzuki","year":"2024","journal-title":"J Diab Complications"},{"key":"10.1016\/j.diabres.2025.112913_b0085","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diacare.27.6.1271","article-title":"Development of a diabetes diet-related quality-of-life scale","volume":"27","author":"Sato","year":"2004","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2025.112913_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13340-016-0291-x","article-title":"Reliability and validity of revised and short form versions of diabetes diet-related quality of life scale","volume":"8","author":"Sato","year":"2017","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2025.112913_b0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1464-5491.1990.tb01421.x","article-title":"Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes","volume":"7","author":"Bradley","year":"1990","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2025.112913_b0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.22.3.530","article-title":"Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur","volume":"22","author":"Bradley","year":"1999","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2025.112913_b0105","unstructured":"The Japanese Version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ): translation and clinical evaluation. Health Psychology Research Ltd n.d. https:\/\/healthpsychologyresearch.com\/publication\/japanese-version-diabetes-treatment-satisfaction-questionnaire\/ (accessed March 13, 2025)."},{"issue":"1","key":"10.1016\/j.diabres.2025.112913_b0110","first-page":"73","article-title":"The general self\u2010efficacy scale (GSES): scale development and validation. Japanese","volume":"12","author":"Sakano","year":"1986","journal-title":"J Behav Ther"},{"key":"10.1016\/j.diabres.2025.112913_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.genhosppsych.2018.03.007","article-title":"Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care","volume":"52","author":"Muramatsu","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.diabres.2025.112913_b0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12955-014-0179-z","article-title":"Reliability and validity of the Japanese version of the Self-Stigma Scale in patients with type 2 diabetes","volume":"12","author":"Kato","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.diabres.2025.112913_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-0025.2010.01030.x","article-title":"Self-stigma among concealable minorities in Hong Kong: conceptualization and unified measurement","volume":"80","author":"Mak","year":"2010","journal-title":"Am J Orthopsychiatry"},{"key":"10.1016\/j.diabres.2025.112913_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40519-023-01573-0","article-title":"Developing and validating a Japanese version of the weight self-stigma questionnaire","volume":"28","author":"Nakamura","year":"2023","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.diabres.2025.112913_b0135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1590\/2175-8239-jbn-2018-0152","article-title":"Quality of life of individuals with chronic kidney disease on dialysis","volume":"41","author":"Jesus","year":"2019","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.diabres.2025.112913_b0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diabres.2019.03.020","article-title":"Assessing the perceived impact of diabetes on quality of life: psychometric validation of the DAWN2 impact of diabetes profile in the second diabetes MILES - Australia (MILES-2) survey","volume":"150","author":"Holmes-Truscott","year":"2019","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112913_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7571838","article-title":"Quality of life assessment in diabetic patients using a validated tool in a patient population visiting a tertiary care center in Bhubaneswar, Odisha, India","volume":"2020","author":"Meher","year":"2020","journal-title":"Scientif World J"},{"key":"10.1016\/j.diabres.2025.112913_b0150","doi-asserted-by":"crossref","DOI":"10.1007\/s13340-025-00829-7","article-title":"Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes","author":"Toga-Sato","year":"2025","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2025.112913_b0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/DMSO.S443396","article-title":"The effect of tirzepatide on weight, lipid metabolism and blood pressure in overweight\/obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Lv","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2025.112913_b0160","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s40200-024-01472-w","article-title":"Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study","volume":"23","author":"Sawamura","year":"2024","journal-title":"J Diab Metab Disord"},{"key":"10.1016\/j.diabres.2025.112913_b0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7570\/jomes24008","article-title":"The effects of tirzepatide on lipid profile: a systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Mahar","year":"2024","journal-title":"J Obesity Metab Syndrome"},{"key":"10.1016\/j.diabres.2025.112913_b0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/dc24-1773","article-title":"Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1\u20135 clinical trials","volume":"48","author":"Apperloo","year":"2025","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2025.112913_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-8587(23)00347-9","article-title":"Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations","volume":"12","author":"Speight","year":"2024","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1016\/j.diabres.2025.112913_b0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2025.112913_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14387","article-title":"At multiple fronts: diabetes stigma and weight stigma in adults with type 2 diabetes","volume":"38","author":"Himmelstein","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2025.112913_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.appet.2016.01.034","article-title":"Weight stigma and eating behavior: a review of the literature","volume":"102","author":"Vartanian","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.diabres.2025.112913_b0195","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/jan.13511","article-title":"Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: a systematic review","volume":"74","author":"Wu","year":"2018","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.diabres.2025.112913_b0200","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae136","article-title":"Diabetes stigma and clinical outcomes: an international review","volume":"8","author":"Eitel","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.diabres.2025.112913_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110774","article-title":"Type 2 diabetes stigma and its association with clinical, psychological, and behavioral outcomes: a systematic review and meta-analysis","volume":"202","author":"Akyirem","year":"2023","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112913_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034757","article-title":"How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study","volume":"10","author":"Kato","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2025.112913_b0215","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2105\/AJPH.2016.303260","article-title":"Evolution of well-being and happiness after increases in consumption of fruit and vegetables","volume":"106","author":"Mujcic","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.diabres.2025.112913_b0220","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fpsyg.2018.00487","article-title":"Intake of raw fruits and vegetables is associated with better mental health than intake of processed fruits and vegetables","volume":"9","author":"Brookie","year":"2018","journal-title":"Front Psychol"},{"key":"10.1016\/j.diabres.2025.112913_b0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1507\/endocrj.EJ23-0320","article-title":"Relationship between diabetes diet-related quality of life and dietary fiber intake among people with type 2 diabetes: a cross-sectional study","volume":"71","author":"Takahashi","year":"2024","journal-title":"Endocr J"},{"key":"10.1016\/j.diabres.2025.112913_b0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.112913_b0235","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.112913_b0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.15333","article-title":"Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials","volume":"26","author":"Patel","year":"2024","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.diabres.2025.112913_b0245","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad016","article-title":"Adverse events related to tirzepatide","volume":"7","author":"Mishra","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.diabres.2025.112913_b0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13300-024-01684-6","article-title":"Characteristics and dosing patterns of tirzepatide users with type 2 diabetes in the United States","volume":"16","author":"Mody","year":"2025","journal-title":"Diabetes Ther"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:25:17Z","timestamp":1764080717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725009271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0168822725009271"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112913","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112913"}}